Results 101 to 110 of about 33,246 (294)

Treatment of Epidermal Pathology in a Pediatric Patient With Keratitis–Ichthyosis–Deafness (KID) Syndrome With Topical Mefenamic Acid

Pediatric Dermatology, EarlyView.
ABSTRACT Keratitis–ichthyosis–deafness (KID) syndrome is a rare genetic condition typically presenting at birth with ichthyosiform erythroderma and bilateral hearing loss and later progressing to diffuse keratodermatous plaques with scaling. The condition is associated with mutations in the GJB2 gene, which lead to aberrant activation of connexin ...
Radhika Gupta, Alisa Ho, Lars Brichta, Albert C. Yan   +3 more
wiley   +1 more source

Psychiatric Adverse Events in Patients Taking Isotretinoin as Reported in a Food and Drug Administration Database From 1997 to 2017.

JAMA dermatology, 2019
Importance Isotretinoin is a highly effective medication for severe acne. Although no causal link between isotretinoin and psychiatric adverse effects has been established, widespread media reporting of depression and suicidality with use of isotretinoin
S. Singer, Elizabeth Tkachenko, Priyanka Sharma, J. Barbieri, A. Mostaghimi   +4 more
semanticscholar   +1 more source

Prescribing Patterns in Pediatric Hidradenitis Suppurativa

Pediatric Dermatology, EarlyView.
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin condition increasingly diagnosed in pediatric populations; however, data on treatment practices in this group remains limited. In this retrospective study of 163 patients diagnosed with HS ≤ 18 years of age, we found that treatment patterns varied significantly by disease severity.
Hannah Neimy, Courtney L. Walker, Lara Wine Lee, Colleen H. Cotton   +3 more
wiley   +1 more source

The effect of low-dose isotretinoin therapy on serum androgen levels in women with acne vulgaris

International Journal of Women's Dermatology, 2020
Background: Acne vulgaris is a common dermatologic disease that causes significant social and psychological morbidity. Isotretinoin, as a vitamin A derivative, is the most effective agent in the treatment of acne.
Amir Feily, MD, Tahere Taheri, MD, Barbara Meier-Schiesser, MD, PhD, Dena P. Rhinehart, MD, Saeed Sobhanian, PhD, Maricarmen Colon-Diaz, PhD, Ahmad Feily, Marigdalia K. Ramirez-Fort, MD   +7 more
doaj   +1 more source

Low dose of isotretinoin: A comprehensive review

Dermatologic Therapy, 2020
Isotretinoin is a first‐generation retinoid initially approved for the treatment of severe cases of acne vulgaris (nodulocystic acne). Because of its broad anti‐inflammatory and immunomodulatory properties, it has been used beyond its initial approval in
A. Abdelmaksoud, T. Lotti, A. Vojvodić, R. Anadolu, M. Goldust, E. Ayhan, D. Dave, M. Vestita, B. Ebik, Mrinal Gupta   +9 more
semanticscholar   +1 more source

Rapid and long‐lasting remission of refractory Hailey‐Hailey disease by IL‐13 inhibition with tralokinumab

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Oliver Brandt, Stephanie M. Huber, Simon M. Mueller   +2 more
wiley   +1 more source

A pilot study of chemoimmunotherapy in the postconsolidation setting for high‐risk neuroblastoma (ANBL19P1): A report from the Children’s Oncology Group

Cancer, Volume 132, Issue 2, 15 January 2026.
Abstract Background Survival for patients with high‐risk neuroblastoma remains poor despite current‐era multimodality treatment that includes postconsolidation GD2‐directed immunotherapy. Given the promising responses in patients who receive dinutuximab‐based chemoimmunotherapy in the relapsed setting, the Children’s Oncology Group ANBL19P1 study ...
Ami V. Desai, Arlene Naranjo, Brian LaBarre, Lulu Chen, Kelly C. Goldsmith, Meaghan P. Granger, Lisa States, Sean G. Green, Mariel Trunzo, Wendy Fitzgerald, Steven G. DuBois, Rochelle Bagatell, Julie R. Park, Araz Marachelian   +13 more
wiley   +1 more source

Isotretinoin induced urethritis: A case report & review of the literature

Urology Case Reports, 2020
We report a case of urethritis in a 17-year-old non-sexually active male that developed after starting isotretinoin treatment for his acne. Clinicians must be vigilant about this adverse effect and elicit a thorough medication history prior to ...
Vivian Paredes-Bhushan, Michael E. Rezaee, David R. Chavez   +2 more
doaj   +1 more source

Response to Reader Comment on “Considerations in Treating Severe Acne With Isotretinoin in Transgender Men” [PDF]

, 2021
Louis Kuritzky, Vincent Richer
openalex   +1 more source

US Food and Drug Administration Reports of Pregnancy and Pregnancy-Related Adverse Events Associated With Isotretinoin.

JAMA dermatology, 2019
Importance iPLEDGE is a rigorous program initiated in 2006 to reduce fetal exposure to isotretinoin, a disease-modifying medication for acne that carries a risk of teratogenesis.
Elizabeth Tkachenko, S. Singer, Priyanka Sharma, J. Barbieri, A. Mostaghimi   +4 more
semanticscholar   +1 more source